Penumbra (PEN) Cash & Equivalents (2014 - 2026)
Penumbra (PEN) reported Cash & Equivalents of $241.3 million for Q1 2026, down 35.84% year-over-year from $376.1 million in Q1 2025, and up 29.1% on a QoQ basis from $186.9 million in Q4 2025.
Penumbra (PEN) has 13 years of Cash & Equivalents data on file, last reported at $241.3 million in Q1 2026.
- Quarterly Cash & Equivalents fell 35.84% year-over-year to $241.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $241.3 million (down 35.84% YoY) and the FY2025 annual result came in at $186.9 million, down 42.39% from the prior year.
- Cash & Equivalents climbed to $241.3 million in Q1 2026 per PEN's latest filing, from $186.9 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $421.8 million in Q2 2025 and bottomed at $54.8 million in Q3 2022.
- The 5-year median for Cash & Equivalents is $186.9 million (2025), against an average of $199.5 million.
- The widest annual swing landed in 2024, when Cash & Equivalents jumped 178.37%; it then plunged 42.39% in 2025.
- Tracing PEN's Cash & Equivalents over 5 years: stood at $69.9 million in 2022, then jumped by 139.75% to $167.5 million in 2023, then soared by 93.69% to $324.4 million in 2024, then sank by 42.39% to $186.9 million in 2025, then climbed by 29.1% to $241.3 million in 2026.
- Per Business Quant, the three latest PEN Cash & Equivalents figures stand at $241.3 million (Q1 2026), $186.9 million (Q4 2025), and $321.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.03 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1.12 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 439.60 Mn |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn | 241.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 241.29 Mn |
| Dec 31, 2025 | 186.90 Mn |
| Sep 30, 2025 | 321.03 Mn |
| Jun 30, 2025 | 421.77 Mn |
| Mar 31, 2025 | 376.05 Mn |
| Dec 31, 2024 | 324.40 Mn |
| Sep 30, 2024 | 280.48 Mn |
| Jun 30, 2024 | 288.33 Mn |
| Mar 31, 2024 | 223.11 Mn |
| Dec 31, 2023 | 167.49 Mn |
| Sep 30, 2023 | 100.76 Mn |
| Jun 30, 2023 | 114.17 Mn |
| Mar 31, 2023 | 94.69 Mn |
| Dec 31, 2022 | 69.86 Mn |
| Sep 30, 2022 | 54.84 Mn |
| Jun 30, 2022 | 58.23 Mn |
| Mar 31, 2022 | 68.16 Mn |
| Dec 31, 2021 | 59.38 Mn |
| Sep 30, 2021 | 66.29 Mn |
| Mar 31, 2021 | 55.63 Mn |
| Dec 31, 2020 | 69.67 Mn |
| Sep 30, 2020 | 80.12 Mn |
| Jun 30, 2020 | 134.38 Mn |
| Mar 31, 2020 | 72.46 Mn |
| Dec 31, 2019 | 72.78 Mn |
| Sep 30, 2019 | 111.58 Mn |
| Jun 30, 2019 | 77.26 Mn |
| Mar 31, 2019 | 67.85 Mn |
| Dec 31, 2018 | 67.85 Mn |
| Sep 30, 2018 | 47.74 Mn |
| Jun 30, 2018 | 59.71 Mn |
| Mar 31, 2018 | 50.64 Mn |
| Dec 31, 2017 | 50.64 Mn |
| Sep 30, 2017 | 65.62 Mn |
| Jun 30, 2017 | 76.58 Mn |
| Mar 31, 2017 | 109.38 Mn |
| Dec 31, 2016 | 13.24 Mn |
| Sep 30, 2016 | 15.86 Mn |
| Jun 30, 2016 | 13.91 Mn |
| Mar 31, 2016 | 17.61 Mn |
| Dec 31, 2015 | 19.55 Mn |
| Sep 30, 2015 | 159.10 Mn |
| Jun 30, 2015 | 36.76 Mn |
| Mar 31, 2015 | 8.13 Mn |
| Dec 31, 2014 | 3.29 Mn |
| Sep 30, 2014 | 8.19 Mn |